INJECT: INvestigation of JETREA in Patients with Confirmed Vitreomacular Traction
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2016
Price : $35 *
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal disorders
- Focus Therapeutic Use
- Acronyms INJECT
- Sponsors Alcon
- 12 May 2016 Status changed from active, no longer recruiting to completed.
- 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical research Network.
- 22 Aug 2014 New trial record